主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2683
Verastem, Inc.
5.7
2
+1.42%
版块:
基础:
利润货币:
日范围
年范围
日变化
+1.42%
每月变动
-11.86%
6个月变化
-38.49%
年变化
+6.32%
前一天收盘价
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
交易量
58
市场
股票
医疗保健
VSTM
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
新闻
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley重申Verastem股票买入评级,维持16美元目标价
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem报告癌症治疗第四季度收入达1750万美元
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
艾伯维或收购Revolution Medicines,后者股价飙升超20%
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Verastem股票稳定 Mizuho重申"优于大盘"评级